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ABSTRACT 
Alzheimer’s disease is one of the most common forms of neurodegenerative disease in which 
the extracellular deposition of fibrils and tangles of the aggregation of amorphous amyloid β-
peptide are found in some part of the brain, mainly in the region responsible for learning, 
memory and emotional behavior. Neurons that use glutamate and acetylcholine as 
neurotransmitter are mainly affected. The disease is caused due to the deposition of Aβ 
amyloid extracellular. The protein AAP is break down into Aβ amyloid fragments by γ- 
secretase and α-secretase enzyme that in later stage forms aggregate. Although α- secretase 
has its chemical structure but γ-secretase which has four subs unit structure has yet not been 
found. Here we will try to predict the structure of these subunits though Ab Initio structure 
prediction method.  And using the subunit structure we will try to predict complex structure.  
 
 
 
Keywords: Alzheimer, neurodegenerative, amyloid, amyloid precursor protein, gamma 
secretase, ab initio  
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1. INTRODUCTION 
Alzheimer’s disease (AD) is one of the most common forms of dementia. The disease mainly 
affects the neuron cells in the brain. Accumulation of plaques and tangles are found in the 
AD patience’s brain [1, 2]. The plaques are extracellular deposition of fibrils and amorphous 
aggregation of the amyloidβ-peptide in high amount. Neurofibrillary tangles are intracellular 
fibrillar aggregation of the microtubules associated tau proteins that are required for the 
neurons growth and maintenance [2].  The plaques and tangles are mainly present in that 
region of the brain which are responsible for learning, memory and emotional behaviors such 
as hippocampus, entorhinal cortex, amygdala and basal forebrain [1]. Brain regions with 
plaques and tangles exhibit reduced number of synapse and the neurons which use glutamate 
and acetylcholine as neurotransmitter are found to be mostly affected.  
      Persons with AD show mild forgetfulness and trouble remembering recent events at the 
beginning and as the disease progresses the person starts losing any sense, like unable to 
remember direction, names, and unable to recognize their own once at late stage 
[http://en.wikipedia.org/wiki/Alzheimer's_disease].  
The most dangerous about this disease is that, there is still no drug that can cure AD. 
Although there are some drugs that can relatively decrease the progress the development of 
the disease as per U.S. Food and Drug Administration (FDA).  
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1.1. Cause of the Disease 
The real cause of this disease is yet not found out but it has been seen that the one of the main 
cause of this disease is the accumulation of amyloid β-peptide protein in some part of the 
brain. Amyloid β-peptide fragments aggregate leading to form fibril like structure which has 
an irreversible cross β structure [34].  Amyloid β-peptides are form from the breakdown of 
APP (amyloid precursor protein) by γ-secretase, α-secretase and β-secretase enzyme. But 
involvement α-secretase remains unclear [35]. APP is a transmembrane protein which has 
many isoforms ranging in size from 695 to 700 amino acids. The most abundant form of 
insoform APP695 found in brain in produced by neuron cell [1].  
Cleavage of APP by α-secretase releases sAPPα from the cell surface and leaves an 83-
amino-acid carboxy-terminal APP fragment (C83). Amyloidogenic processing of APP 
involves sequential cleavages by β-secretase and γ-secretase at the N and C terminal of Aβ 
respectively. The 99-amino-acid C-terminal fragment of APP cleaved by β-secretase.  
 
               
Figure.1. - Breakdown of APP by β-secretase and γ-secretase enzyme and formation of Aβ40/42, key 
fragment to the amyloid aggregation. 
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Cleavage can be internalized and further processed by γ-secretase to produce Aβ40/42 in 
extracellular.  Cleavage of C99 by γ-secretase liberates an APP intracellular domain that can 
translocate to the nucleus where it may regulate gene expression, including the induction of 
apoptotic genes. Cleavage of APP/C99 by caspases produces a neurotoxic peptide (C31)67. 
Aβ40/42 fragment forms aggregate and in later stage an irreversible fibril like structure which 
has a cross β-sheet structure. This irreversible fibril like structure accumulates in some part of 
the brain mainly in synaptic junctions where the presence of APP is more. 
AD tough is not inherited from parents but through molecular genetics it is found that the 
individual that produces more apoliprotein E4 has higher risk of getting AD. The mechanism 
whereby E4 promotes AD is not established, but there is evidence that E4 enhances Aβ 
aggregation and reduces Aβ clearance. In addition, data suggest that E4 might increase the 
risk of AD by enhancing amyloidogenic processing of APP, increasing oxidative stress and 
impairing neuronal plasticity [7].  
Other factor that may enhance the susceptibility of AD to a person is the mutation in APP, 
PS1 and PS2 genes. Mutation in these genes increases the production of long 42 amino acid 
form of Aβ (Aβ42) part in APP. 
1.2. Harmful Effects 
APP is required for the growth and maintenance of the neuron cells. Perturbed processing of 
APP resulting in increased production of Aβ at synapses may be an early event in AD. APP is 
axonally transported and Aβ therefore likely accumulates at synapses in high amounts in AD. 
Aβ can have multiple adverse effects on the functions and integrity of both pre- and 
postsynaptic terminals including inducing oxidative stress, impairing calcium homeostasis 
and perturbing the functions of mitochondria and the ER. The increased Aβ deposition that 
occurs in AD most probably contributes to the demise of neurons because Aβ can be directly 
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toxic to neurons and also greatly increases their vulnerability to oxidative and metabolic 
stress, and toxicity. 
Another effect of accumulation of Aβ peptide extracellular is the induced production of 
highly oxidative free-radicals. The neurotoxic action of Aβ involves generation of reactive 
oxygen species and disruption of cellular calcium homeostasis. Interactions of Aβ oligomers 
and Fe+² or Cu+ generate hydrogen peroxide. When Aβ aggregation occurs at the cell 
membrane, membrane-associated oxidative stress results in lipid peroxidation and the 
consequent generation of 4-hydroxynonenal (4HNE), a neurotoxic aldehyde that covalently 
modifies proteins on cysteine, lysine and histidine residues. Oxidative modifications of tau 
protein by 4HNE and other reactive oxygen species can promote its aggregation and may 
thereby induce the formation of neurofibrillary tangles. Aβ can also cause mitochondrial 
oxidative stress and deregulations of Calcium homeostasis, resulting in impairment of the 
electron transport chain, increased production of superoxide anion radical and decreased 
production of ATP.  
Fe+² or Cu+ generates the hydroxyl radical (OH), a highly reactive oxyradical and potent 
inducer of membrane-associated oxidative stress that contributes to the dysfunction of the 
ER. 
1.3. Therapeutic approach 
The γ-secretase, which cleaves APP within a transmembrane region, involves four different 
proteins, presenilin, nicastrin, Aph-1 and Pen-2. The active site of γ-secretase requires the 
aspartyl protease activity of PS1 conferred by aspartate residues in adjacent transmembrane 
domains of the C- and N-terminal cleavage fragments of PS1 (red star). Nicastrin, Pen-2 and 
Aph-1 are each critical components of γ-secretase and each may modify enzyme activity in  
 
9 
  
 
 
 
Figure.2: - Representation of the four sib units of γsecretase enzyme, namely Aph-1, Presenilin, Nicastrin 
and Pen-2 
 
specific ways and in response to physiological stimuli. APP is only one of several proteins 
that are cleaved by γ-secretase. 
The best way to stop this AD is either we inhibit the γ-secretase and β-secretase enzyme or 
we inhibit the aggregation of amyloid β-peptide or reverse the fibril structure. But to inhibit 
the β-secretase and γ-secretase enzyme, we must know the structure of the enzyme. The 
structure of β-secretase is known but the structure of γ-secretase and its four sub unit is still 
not known, although structure of presenilin is in CASP12 list. 
 
1.4. Objective 
 The objective of this project is ‘to predict the structure of sub units of γ-secretase 
enzyme and using this structure to predict the structure of the complex γ-secretae 
enzyme’. 
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2. LITERATURE REVIEW 
The main objective is to predict the structure of the γ-secretase protein using the best known 
method available. Homology modeling method is best for those sequences which have 
template similarity more than 80% [Chung SY et al, 1996, 126-141]. Ab initio modeling [8–
10], method is best in terms of the accuracy but success is limited to small proteins with < 
120 amino acids [3, 11]. And from the literature review it is found that during the CASP 
experiment the I-TASSER method have shown significant advantages of composite 
approaches in protein structure prediction [11, 13], which combine various techniques such as 
threading, ab initio modeling and atomic-level structure refinement approaches[13, 17].  
 I-TASSER (iterative threading assembly refinement) [10], an automated protein structure 
prediction method has been listed as the best method for the automated protein structure 
prediction in the last two CASP experiments [13, 17]. I-TASSER assisted by the sequence 
profile and the predicted secondary structure, the query sequence is then threaded through a 
representative PDB structure library using LOMETS, a locally installed meta-threading 
server combining seven state-of-the-art threading programs. The model selected is done 
Monte Claro Stimulation to select the best model. 
Detailed descriptions of the I-TASSER methodology for protein structure and function 
prediction have been in following steps- 
Threading > structure assembly > model selection and refinement > structure based 
functional annotation. 
In here we have done differently with PDB-BLAST, and in structure selection we have used 
Ramachandran plot [K.Gopalakrishna et al, 2007, 14,699-671] and Z-score and Docking for 
the minimized model structures. The secondary structure generated was compared with the 
annotated structure information given for each of the four sub units.  
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3. MATERIALS & METHODS  
1.1.Amino Acid Sequence Search:  
The amino acid sequence of sub units; presenilin, nicastrin, pen2 and aph1 are 
searched in the NCBI database. NCBI (http://www.ncbi.nlm.nih.gov/) database is part 
on United States National Library of Medicines, a branch of National Institute of 
Health. Sequence of all the sub units are searched using Entrez search engine. 
  1. Amino acid Sequence of PEN-2 sub unit in FASTA format: 
>gi|28144920|ref|NP_758844.1| gamma-secretase subunit PEN-2 [Homo sapiens] 
MNLERVSNEEKLNLCRKYYLGGFAFLPFLWLVNIFWFFREAFLVPAYTE
QSQIKGYVWRSAVGFLFWVIVLTSWITIFQIYRPRWGALGDYLSFTIPLG
TP 
 
2. Amino acid Sequence of APH-1 subunit in FASTA format : 
>gi|344313184|ref|NP_001230700.1| gamma-secretase subunit APH-1A isoform 3 
[Homo sapiens] 
MGAAVFFGCTFVAFGPAFALFLITVAGDPLRVIILVAGKADEGLASLSED
GRSPISIRQMAYVSGLSFGIISGVFSVINILADALGPGVVGIHGDSPYYFLTS
AFLTAAIILLHTFWGVVFFDACERRRYWALGLVVGSHLLTSGLTFLNPW
YEASLLPIYAVTVSMGLWAFITAGGSLRSIQRSLLCKD  
 
3. Amino acid sequence of Nicastrin subunit in FASTA format: 
 >gi|9992878|gb|AAG11412.1|AF240468_1 nicastrin [Homo sapiens] 
MATAGGGSGADPGSRGLLRLLSFCVLLAGLCRGNSVERKIYIPLNKTAPC
VRLLNATHQIGCQSSISGDTGVIHVVEKEEDLQWVLTDGPNPPYMVLLES
KHFTRDLMEKLKGRTSRIAGLAVSLTKPSPASGFSPSVQCPNDGFGVYSN
12 
  
 
 
SYGPEFAHCREIQWNSLGNGLAYEDFSFPIFLLEDENETKVIKQCYQDHN
LSQNGSAPTFPLCAMQLFSHMHAVISTATCMRRSSIQSTFSINPEIVCDPLS
DYNVWSMLKPINTTGTLKPDDRVVVAATRLDSRSFFWNVAPGAESAVAS
FVTQLAAAEALQKAPDVTTLPRNVMFVFFQGETFDYIGSSRMVYDMEKG
KFPVQLENVDSFVELGQVALRTSLELWMHTDPVSQKNESVRNQVEDLLA
TLEKSGAGVPAVILRRPNQSQPLPPSSLQRFLRARNISGVVLADHSGAFHN
KYYQSIYDTAENINVSYPEWLSPEEDLNFVTDTAKALADVATVLGRALYE
LAGGTNFSDTVQADPQTVTRLLYGFLIKANNSWFQSILRQDLRSYLGDGP
LQHYIAVSSPTNTTYVVQYALANLTGTVVNLTREQCQDPSKVPSENKDLY
EYSWVQGPLHSNETDRLPRCVRSTARLARALSPAFELSQWSSTEYSTWTE
SRWKDIRARIFLIASKELELITLTVGFGILIFSLIVTYCINAKADVLFIAPRE
PGAVSY 
 
4. Amino Acid sequence of Presenilin in FASTA format: 
>gi|119601503|gb|EAW81097.1| presenilin 1 (Alzheimer disease 3), isoform CRA_b 
[Homo sapiens] 
MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEP
LSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVV
ATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTIL
LVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVAL
LIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLI
LAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNM
AEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSH
LGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASA
13 
  
 
 
TASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATD
YLVQPFMDQLAFHQFYI 
 ncbi.nlm.nih.gov > protein database > name of the protein [Homo sapiens] 
1.2. BLAST: 
Protein-protein BLAST is done for each of the four sub units. But the similarity among the 
sub units of the similarity is found to be less than 80%. E-value in BLAST search measures 
the probability that the search result in non-random. 
ncbi.nlm.nih.gov > protein database > name of the protein [Homo sapiens] > select the 
FASTA sequence or Accession number > select PDB protein database > run protein-protein 
BLAST 
1.3. Secondary Structure Prediction: 
Secondary structure is predicted using Chou & Fasman online server. This method works on 
the principle of probability parameters determined from relative frequencies of each amino 
acid's appearance in each type of secondary structure. The algorithm followed by Chou & 
Fasman in that it assigns certain probability value to residues weather it will be helix, coil or 
stand and calculate on the basis of propensity of the structure among certain number of 
risidues.  
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Sub Unit Secondary Structure Total Residue Percentage of the 
total Residue 
Presenilin  
(467 amino acids) 
α- helix(H) 365 78.2 
β- sheet(E) 50 10.7 
β-turn(T) 311 66.6 
Nicastrin  
(709 amino acids) 
α-helix(H) 459 64.9 
β-sheet(E) 97 13.7 
β-turn(T) 454 64.0 
PEN-2  
(101 amino acids) 
α-helix(H) 74 73.3 
β-sheet(E) 10 9.9 
β-turn(T) 74 73.3 
Aph-1 
(190 amino acids) 
α-helix(H) 148 77.9 
β-sheet(E) 16 8.4 
β-turn(T) 119 62.4 
 
Table.1: - Secondary dtructure prediction of all sub units by Chou & Fasman method 
 
1.4. I-TASSER Prediction Method 
I-TASSER (Iterative Threading Assembly Refinement) is a unified platform for automated 
protein structure and functional prediction based on the sequence to structure and from 
structure to functional paradigm [Amboish Roy et al, 2005]. The threading is done with the 
help of a eight state of art threading software called LOMET [Sitao Wu et al, 2007], that 
includes FUGUE, PROSPECT2, SPARKS2, SAM-To, HHSERACH, PPA-I, PPA-II and 
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PAINT threading method. All the structures generated by these threading methods are 
assembled and being analyzed to get the best ten model structures for the sub units.  
      
   
Figure.3:-I-TASSER prediction models for Pen-2 sub unit.  
Pen-2 
 (Number of groups-101, 
number of atoms-859 & 
number of bonds-892) 
Number of Helix 
(H)  
 
Number of Turns 
(T)  
 
Number of Sheet 
(E) 
 
Model1  6 9 0 
Model2  3 2 0 
Model3 4 5 0 
Model4  5 11 0 
Model5 5 8 0 
 
Table.2: - Comparison of different models of Pen-2 sub unit generated by I-TASSER. 
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Figure.4: - I-TASSER predicted models for Nicastrin sub unit. 
 
Nicastrin 
(Number on groups-709, 
number of atoms-5523, 
number of -5654)  
Number of 
Helix(H)  
Number of Turn 
(T) 
Number of Sheet 
(E) 
Model1 22 78 20 
Model2 25 83 21 
Model3 22 75 21 
 
Table.3: - Comparison of different models of Nicastrin sub unit generated by I-TASSER. 
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Figure.5: - Different models generated byI-TASSER for Aph-1 sub unit. 
 
Aph1(Number of groups-190, 
number of atoms-1433 & 
number of bonds-1471) 
Number of 
Helix(H) 
 
Number of 
Turn(T) 
 
Number of 
Sheet(E) 
 
Model1 8 13 0 
Model2 12 12 0 
Model3 12 13 0 
Model4 12 13 0 
Model5 8 10  0 
 
Table.4. - Comparison of different models of Aph-1 sub unit generated by I-TASSER. 
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Fig.6: - Sequence of Presenilin sub unit is in CASP12 (Critical Assessment of Protein Structure Prediction 
2012), therefore the structure is predicted by BhageeratH, not by I-TASSER. 
The structure of each sub unit generated is compared with the annotated structure 
given in the ChEMBL Uniprot/ SwissProt. Although the annotated structure shows only 
potential of the secondary structure and thus not indicate the exact structure of the 
sequence. Comparing the structure predicted using I-TASSER method, the structures 
are having similarity with annotated structure information. 
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1.5. STRUCTURE VALIDATION 
1.5.1. Ramachandran Plot 
A Ramachandran plot is a way to visualize backbone dihedral angle ψ (psi) against φ (pi) 
of amino acid residues in protein structure. Ψ angle is the angle between the bonds from the 
α-carbon to the carbonyl group (at the C-terminus) of the amino acid. The φ angle is angle 
between the bonds from the nitrogen (at the N-terminus) to the α-carbon of the amino acid 
residue. We can vary ψ from –180° to 180° and we can vary φ from –180° to 180° (that is 
360° of rotation for each). But all the angles in a protein cannot be rotated due many 
constrains, like steric resistance, partial double bond characters etc. 
Understanding the steric limitations in individual amino acid residues reveals how these 
limitations result in the observed types of secondary structures found in nature.  
The complex folding of proteins is controlled, in a large part, by the limitations on the ψ and 
φ angles available to each amino acid residue. Two main amino acids that contribute in the 
Ramachandran plot are Glycine and Proline. Glycine does not have steric hindrance to other 
19 amino acids. Proline residues are conformationally restricted due to the ring being part of 
the backbone. In general practice, glycine and proline residue data is not plotted in 
Ramachandran plots. 
Though the plot of the models we can find out which models has highest number of residue 
in the allowed region and favored region. Based on the number of residue in the allowed 
region and favored region the models are being selected for the Energy minimization. 
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Sub unit Models Favored region Allowed region Outlier region 
Aph-1 Model1 172 11 5 
Model2 174 8 6 
Model3 173 12 3 
Model4 167 17 6 
Model5 176 8 4 
Pen-2 Model1 96 2 1 
Model2 94 5 0 
Model3 94 2 3 
Model4 88 8 3 
Model5 88 6 5 
Nicastrin Model1 581 74 52 
Model2 568 82 57 
Model3 583 71 53 
Presenilin Molde1 273 166 16 
Model2 288 158 9 
Model3 326 119 10 
Model4 258 184 13 
Model5 345 106 14 
 
Table.5: Ramachandran Analysis of different models 
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1.5.2. Swiss PDB Structure assessment 
SwissPDB structural assessment is based on the Qmean6 value and the Z-score. Qmean6 
value is a global scoring function [Benkert et al. 2008] is a linear combination of six 
structural descriptors using statistical potentials: analyze torsion angle potential and distance-
dependent interaction potentials. A solvation potential investigates the burial status of the 
residues. Two additional terms describing the agreement of the predicted (from sequence) 
and the calculated secondary structure and solvent accessibility of the model. 
Z-scores of the Qmean composite score provides relative quality estimates to scores obtained 
for high-resolution reference structures solved experimentally by X-ray crystallography 
[Benkert et al. 2011]. The Qmean and Z-score represents a measure of the absolute quality of 
a model. Models of low quality are expected to have strongly negative Qmean Z-scores.  
Sub unit Assessment 
Values 
Model1 Model2 Model3 Model4 Model5 
Aph-1 Qmean value 0.388 0.292 0.090 0.259 0.302 
Z-score -3.91 -4.90 -6.96 -5.24 -4.79 
Pen-2 Qmean value 0.354 0.305 0.273 0.414 0.352 
Z-score -3.53 -3.97 -4.27 -2.98 -3.97 
Presenilin  Qmean value 0.435 0.246 0.239 0.209 0.401 
Z-score -3.35 -4.21 -4.58 -4.37 -2.90 
Nicastrin  Qmean value 0.350 0.262 0.298   
Z-score -4.57 -5.54 -5.15   
                         
Table.6: - SwissPDB structural assessment of different models.  
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Figure.7: - Selected I-STRUCTURE models viewed with Chimera of four sub units (A) Aph-1, 
(B).Nicastrin (C). Presenilin and (D). Pen-2 with red, blue and green colors representing strand, helix and 
coil respectively. 
1.6.Energy Minimization 
Stable states of molecular systems correspond to global and local minima on their potential 
energy surface. Starting from a non-equilibrium molecular geometry, energy minimization 
employs the mathematical procedure of optimization to move atoms so as to reduce the net 
forces, the gradients of potential energy on the atoms until they become negligible. 
Like molecular dynamics and Monte-Carlo approaches, periodic boundary conditions have 
been allowed in energy minimization methods, to make small systems.  
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There are two methods for minimization of energy of a protein structure model. 
1. Steepest Descent Method 
This method uses the first derivative to determine the direction towards minimum. The 
energy is calculated at the initial geometry and again calculated in after one of the atoms is 
moved in a small increment in one of the direction of the coordinate system. The process in 
continued for each atom until the predetermined minimum threshold energy is reached. 
2. Conjugate Gradient Method 
This technique uses information from previous derivatives to determine the optimum 
direction for line search. The gradient is calculated at each step which serves as additional 
procedure for better minimization. Hence each step refines the direction towards the 
minimum and thus this method follows after the Steepest Descent method.  
In here we have used the same methods for minimization of the energy of the selected models 
using the Chimera Software. In this software first steepest descent method is done and then 
conjugates gradient method in done. 
During the minimization step, the water molecules, ligands which are bind to the protein 
molecule are being removed and the Hydrogen bond is added to the structure to make it more 
stable. 
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Figure.8: - (A). Example showing comparison between the template model structures (Without 
energy minimization) and (B).the minimized structure of the same structure. 
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Figure.9: - Minimized structure selected models of the (A).Nicastrin, (B).Pen-2, (C).Presenilin and (D). 
Aph-1 
1.7. DOCKING 
Docking is the method to determine the interaction between different molecules. We can 
predict the active site of the molecules where another molecule can come and bind to it. 
The orientation of the molecules which is preferred can also be determined [Lengauer T 
et al, (1996)]. Knowledge of the preferred orientation in turn may be used to predict the 
strength of association or binding affinity between two molecules using for 
example scoring functions. The interaction can be of many types like- 
1. Protein-protein  
2. Ligand-protein 
3. Ligand-ligand 
1.7.1. Docking Using Hex6.3 software 
Hex is an interactive protein docking and molecular superposition program, written 
by Dave Ritchie. Hex6.3 understands protein and DNA structures in PDB format, and 
it can also read small-molecule SDF files. 
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The docking was done in a sequential manner [Figure.2 represents the sequence of sub unit]. 
Since the Aph-1 remains towards the surface it has been docked with the Presenilin. Then the 
resultant structure was docked with the Nicastrin. Than the resultant of the from these three 
sub units was docked with Pen-2 sub unit.  
In second case the sequence of docking was just change from the other side, i.e. Pen-2 with 
Nicastrin and the resultant structure was docked with Presenilin sub unit. Then the resultant 
structure of these three sub units was docked with the Aph-1 sub unit. 
1
st
 Docking step: - Aph-1 sub unit with Presenilin sub unit 
 
Figure.10: Docking result between Aph-1 and Presenilin sub unit. The energy was obtained as -704.20kJ. 
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Figure.11:- The resultant structure of the docking between Aph-1 and Presenilin 
2
nd
 docking step: The resultant structure from Ahp-1 and Presenilin with Nicastrin sub 
unit 
 
Figure.12: Docking result of Aph-1 and Presenilin with Nicastrin. The energy was found to be -663.84kJ 
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Figure.13: Resultant structure of the docking between Aph-1 and Presenilin with Nicastrin 
3
rd
 Docking step: The resultant structure of Aph-1, Presenilin and Nicastrin with Pen-2 
sub unit. 
 
Figure.14: - Docking result of all the four sub units with energy of -643.81 kJ 
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Figure.15: The final docking resultant structure of all the sub units. 
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4. RESULTS AND DISCUSSION 
4.1. RESULT 
Using the I-TASSER method we have got secondary structure for three sub units, but for 
Presenilin, the I-TASSER couldn’t generate the secondary structure because the sequence 
is listed in the CASP12(Critical Assessment of Protein Structure) project. The secondary 
structures generated are almost similar to that has been annotated in the EMBL-
UniprotKB.  
The final docking result from two different ways performed is having different energy 
level. The final docked using (((Aph-1+Presenilin)+Nicastrin)+Pen-2) was found to be -
643.81kJ, whereas for the (((Pen-2+Nicastrin)+Presenilin)+Aph-1) resulted into an 
energy of -499.78kJ. 
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Figure.16: (A). Shows the Docking result from Pen-2 with Nicastrin with Presenilin and then with Aph-1, 
(B). Shows the docking result from Aph-1 with Presenilin and then with Nicastrin and at last with Pen-2 
         
 
Figure.17: (A). structure generated by Aph-1 with Presenilin and then with Nicastrin and then with Pen-2 
(B). Structure generated via Pen-2 with Nicastrin, then with Aph-1  
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4.2. DISCUSION 
The secondary structure prediction was not having similarity more than 80%, therefore we 
couldn’t do the Homology modeling. Using the Modeller software also the Script for the 
secondary prediction shows no topology for the given sequence. Thus the I-TASSER method 
was best for such sequences which use the threading method to recognize the fold of 
particular protein sequence. The secondary structure for Presenilin was not generated by I-
TASSER because in CASP12 (Critical Assessment of Protein Structure Prediction 2012), 
Presenilin has been taken for experimental determination of the structure. The secondary 
structure for the Presenilin was predicted by BhageeratH online server.  
 
Figure.18: Ramachandran Plot of the tertiary structure generated from all the sub units. 
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From the Ramachandran Plot analysis of the structure generated was done with the favored 
region, allowed region and the outlier region which shows the structure generated is good.  
Docked result of all the sub units 
(998 residues) 
Number of Residue Percentage of the total 
Favored Region 664 67.07 
Allowed Region 301 30.16 
Outlier Region 25 2.53 
 
Table.7: Ramachadran Plot analysis of the tertiary structure generated using all the sub units of the γ-
seretase enzyme 
The secondary structure generated using the I-TASSER method and that of the annotated 
information about the secondary structure in the ChEMBL Uniprot/ SwissProt are similar in 
nature.  
The structure annotation is the potential structure for that particular sequence. And the 
structure predicted is having similarity but in case if Nicastrin the similarity is less indicating 
that there is error in the method or the annotation. 
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5. CONCLUSION  
The tertiary structure of the γ-secretase enzyme is being predicted with most number of 
residues in the favored region in Ramachandran Plot. The residue in favored region and the 
allowed regions are fine with 67.07% and 30.16% of the total residue respectively. This 
indicates good interaction the of sub unit structures to form the complex structure of γ-
secretase enzyme.   
The secondary structure predicted has similarity compared to the annotated structure 
information in SwissProt/ChEMBL UniProt. 
But the structure we have generated is not the perfect structure of the γ-secretae enzyme. The 
dynamics of each atoms present in the structure needs to be studied and the other stimulations 
are also to be considered. Orientation of each bonds in the structure needed Flexible Docking 
which takes three to four days in a single docking.  
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